Alzheimer disease: 100 years later;Enfermedad de Alzheimer: Un siglo después

Revista Medica de Chile

Volumn 129, Issue 5, 2001, Pages 569-575

  Puglielli, Luigi ^a   Kovacs, Dora M ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Alzheimer disease; Amyloid beta Protein; Genetics, biochemical; Molecular biology

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN;

ALZHEIMER DISEASE; GENETIC POLYMORPHISM; GENETICS; HUMAN; REVIEW;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; HUMANS; POLYMORPHISM, GENETIC;

EID: 0035348956     PISSN: 00349887     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. DE STROOPER D, ANNAERT W. Proteolytic processing and cell biological functions of the amyloid precursor protein. J Cell Sci 2000; 113: 1857-70.
2. SISODIA SS. Alzheimer's disease: perspectives for the new millennium. J Clin Invest 1999; 104: 1169-70.
3. TANZI RE. A genetic dichotomy model for the inheritance of Alzheimer's disease and common age-related disorders. J Clin Invest 1999; 104: 1175-79.
4. MORRIS JC. Is Alzheimer's disease inevitable with age?: Lessons from clinicopathologic studies of healthy aging and very mild alzheimer's disease. J Clin Invest 1999; 104: 1171-3.
5. SELKOE DJ. Translating cell biology into therapeutic advances in Alzheimer's disease. Nature 1999; 399: A23-31.
6. MESULAM MM. Neuroplasticity failure in Alzheimer's disease: bridging the gap between plaques and tangles. Neuron 1999; 24: 521-9.
7. GOATE A, CHARTIER-HARLIN MC, MULLAN M, BROWN J, CRAWFORD F, FIDANI L, ET AL. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991; 349: 704-6.
8. SHERRINGTON R, ROGAEV EI, LIANG Y, ROGAEVA EA, LEVESQUE G, IKEDA M, ET al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 1995; 375: 754-60.
9. LEVY-LAHAD E, WASCO W, POORKAJ P, ROMANO DM, OSHIMA J, PETTINGELL WH, ET AL. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 1995; 269: 973-7.
10. SAUNDERS AM, STRITTMATTER WJ, SCHMECHEL D, ST GEORGE-HYSLOP PH, PERICAK-VANCE MA, JOO SH, ET AL. Association of apolipoprotein E allele epsilon4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993; 43: 1467-72.
11. BLACKER D, WILCOX MA, LAIRD NM, RODES, L, HORVATH SM, GO RC, ET AL. Alplia-2 macroglobulin is genetically associated with Alzheimer disease. Nat Genet 1998; 19; 357-60.
12. GUENETTE SY, CHEN J, JONDRO PD, TANZI RE. Association of a novel human FE65-like protein with the cytoplasmic domain of the β-amyloid precursor protein. Proc Natl Acad Sci USA 1996; 93: 10832-7.
13. HOMAYOUNI R, RICE DS, SHELDON M, CURRAN T. Disabled-1 binds to the cytoplasmic domain of amyloid precursor-like protein 1. J Neurosci 1999; 19: 7507-15.
14. BORG JP, OOI J, LEVY E, MARGOLIS B. The phosphotyrosine interaction domains of X11 and FE65 bind to distinct sites on the YENPTY motif of amyloid precursor protein. Mol Cell Biol 1996; 16: 6229-41.
15. NISHIMOTO I, OKAMOTO T, MATSUURA Y, TAKAHASHI S, OKAMOTO T, MURAYAMA Y, OGATA E. Alzheimer amyloid protein precursor complexes with brain GTP-binding protein G. Nature 1993; 362: 75-9.
16. CHOW N, KORENDERG JR, CHEN X-N, NEVE RL. APPBP1, a Novel Protein That Binds to theCarboxyl-terminal Region of the Amyloid Precursor Protein J Biol Chem 1996; 271: 11339-46.
17. THINAKARAN G. The role of presenilin in Alzheimer's disease. J Clin Invest 1999; 104: 1321-27.
18. HAASS C. Presenilins: genes for life and death. Neuron 1997; 18: 687-90.
19. SHEN J, BRONSON RT, GHEN DF, XIA W, SELKOE DJ, TONEGAWA S. Skeletal and CNS defects in Presenilin-1-deficient mice. Cell 1997; 89: 629-39.
20. WONG PC, ZHENG H, CHEN H, BECHER MW, SIRINATHSINGHJI DJ, TRUMBAUER ME, ET AL. Presenilin 1 is required for Notchl and Dili expression in the paraxial mesoderm. Nature 1997; 387: 288-92.
21. HARTMANN D, STROOPER BD, SAFTIG P. Presenilin-1 deficiency leads to loss of Cajal-Retzius neurons and cortical dysplasia similar to human type 2 lissencephaly. Curr Biol 1999; 9: 719-27.
22. DE STROOPER B, SAFTIG P, CRAESSAERTS K, VANDEKSTICHELE H, GUHDE G, ANNAERT W, ET AL. Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. Nature 1998; 391: 387-90.
23. HERREMAN A, HARTMANN D, ANNAERT W, SAFTIG P, CRAESSAERTS K, SERNEELS L, ET AL. Presenilin 2 deficiency causes a mild pulmonary phenotype and no changes in amyloid precursor protein processing but enhances the embryonic lethal phenotype of presenilin 1 deficiency. Proc Natl Acad Sci USA 1996; 96: 11872-77.
24. HAASS C, DE STROOPER B. The Presenilins in Alzheimer's Disease. Proteolysis Holds the Key. Science 1999; 286: 916-9.
25. WOLFE MS, DE LOS ANGELES J, MILLER DD, XIA W, SELKOE DJ. Are presenilins intramembrane-cleaving proteases? Implications for the molecular mechanism of Alzheimer's disease. Biochemistry 1999; 38: 11223-30.
26. ESLER WP, KIMBERLY WT, OSTASZEWSKI BL, DIEHL TS, MOORE CL, TSAI J-Y ET AL. Transition-state analogue inhibitors of β-secretase bind directly to presenilin-1. Nature Cell Biol 2000; 2: 428-34.
27. BALES KR, VERINA T, DODEL RC, Du Y, ALTSTIEL L, BENDER M, ET AL. Lack of apolipoprotein E dramatically reduces amyloid β-peptide deposition. Nat Genet 1997; 17: 203-64.
28. BALES KR, VERINA T, CUMMINS DJ, Du Y, DODEL RC, SAURA J, ET AL. Apolipoprotein E is essential for amyloid deposition in the APPV717F transgenic mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 1999; 96: 15233-38.
29. HOLTZMAN DM, BALES KR, WU S, BHAT P, PARSADANIAN M, FAGAN AM, ET AL. Expression of human apolipoprotein E reduces amyloid-β deposition in a mouse model of Alzheimer's disease. J Clin Invest 1999; 103: R15-21.
30. KOVACS DM. α-2-Macroglobulin in late-onset Alzheimer's disease. Exp Geront 2000; 35: 473-9.
31. LA DU MJ, FALDUTO MT, MANELLI AM, REARDON, CA, GETZ GS, FRAIL DE. Isoform-specific binding of apolipoprotein E to β-amyloid. J Biol Chem 1994; 269: 23403-6.
32. NARITA M, HOLTZMAN DM, SCHWARTZ AL, BU G. Alpha2-macroglobulin complexes with and mediates the endocytosis of β-amyloid peptide via cellsurface low-density lipoprotein receptor-related protein. J Neurochem 1997; 69: 1904-11.
33. QIU Z, STRICKLAND, DK, HYMAN BT, REBECK GW. Alpha2-macroglobulin enhances the clearance of endogenous soluble beta-amyloid peptide via low-density lipoprotein receptor-related protein in cortical neurons. J Neurochem 1999; 73: 1393-98.
34. PILLOT T, GOETHALS M, NAJIB J, LABEUR C, LINS L, CHAMBAZ J, ET AL. β-amyloid peptide interacts specifically with the carboxy-terminal domain of human apolipoprotein E: relevance to Alzheimer's disease. J Neurochem 1999;72: 230-7.
35. PARESCE DM, CHUNG H, MAXFIELD FR. Slow degradation of aggregates of the Alzheimer's disease amyloid beta-protein by microglial cells. J Biol Chem 1997; 272: 29390-7.
36. CHUNG H, BRAZIL MI, SOE TT, MAXFIELD FR. Uptake, degradation, and release of fibrillar and soluble forms of Alzheimer's amyloid beta-peptide by microglial cells. J Biol Chem 1999; 274: 32301-8.
37. VASSAR R, BENNETT BD, BABU-KHAN S, KAHN S, MENDIAZ EA, DENIS P, ET AL. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 1999; 286: 735-41.
38. SINHA S, ANDERSON JP, BARBOUR R, BASI GS, CACCAVELLO R, DAVIS D, ET AL. Purification and cloning of amyloid precursor protein beta-secretase from human brain. Nature 1999; 402: 537-40.
39. YAN R, BIENKOWSKI MJ, SHUCK ME, MIAO H, TORY MC, PAULEY AM, ET AL. membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity. Nature 1999; 402: 533-7.
40. HUSSAIN I, POWELL D, HOWLETT DR, TEW DG, MEEK TD, CHAPMAN C, ET AL. Identification of a novel aspartic protease (Asp 2) as beta-secretase. Mol Cell Neurosci 1999; 14: 419-27.
41. SKOVRONSKY DM, LEE VM-Y. β-secretase revealed: starting gate for race to novel therapies for Alzheimer's disease. Trends Pharmacol Sci 2000; 21: 161-3.
42. VASSAR R, CITRON M. Aβ-generating enzymes: recent advances in β-and γ-secretase research. Neuron 2000; 27: 419-22.
43. SCHENK D, BARBOUR R, DUNN W, GORDON G, GRAJEDA H, GUIDO T, ET AL. Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 1999; 400: 173-7.